Every SEC Form 3/4/5 on record for this filer (CIK 1533568) — 11 issuers, 52 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ARVN | ARVINAS, INC. | Director | 2019-07-26 → 2026-06-26 | 9 | — |
| NBIX | NEUROCRINE BIOSCIENCES INC | Director | 2019-09-12 → 2026-06-08 | 15 | −$3M |
| CVS | CVS HEALTH Corp | Director | 2024-11-25 → 2026-05-15 | 5 | — |
| GMED | GLOBUS MEDICAL INC | Director | 2023-09-06 → 2026-01-23 | 9 | −$1M |
| MODV | ModivCare Inc | Director · lapsed | 2021-02-12 → 2024-02-16 | 4 | — |
| NUVA | NUVASIVE INC | Director · lapsed | 2016-05-23 → 2023-09-05 | 11 | — |
| CNC | CENTENE CORP | Director · lapsed | 2022-01-18 → 2022-04-04 | 3 | — |
| MGLN | MAGELLAN HEALTH INC | Director · lapsed | 2019-04-05 → 2022-01-04 | 6 | — |
| PRSC | PROVIDENCE SERVICE CORP | Director · lapsed | 2015-11-05 → 2020-02-18 | 7 | — |
| ELGX | ENDOLOGIX INC /DE/ | Director · lapsed | 2016-06-03 → 2019-08-06 | 4 | — |
| PGND | Press Ganey Holdings, Inc. | Director · lapsed | 2015-07-20 → 2016-10-25 | 3 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| NBIX | 2026-06-04 | Sell | 1,250 | $168.06 | $210,075 | 2,838 |
| NBIX | 2026-05-12 | Sell | 3,810 | $155.01 | $590,588 | 2,429 |
| GMED | 2026-01-08 | Sell | 2,000 | $101.10 | $202,200 | 10,419 |
| NBIX | 2025-12-16 | Sell | 1,190 | $155.09 | $184,557 | 6,239 |
| NBIX | 2025-12-15 | Sell | 5,000 | $152.23 | $761,150 | 7,429 |
5 of 11 issuers are covered and open a security page; the rest are on file here only.
